LRH-1-dependent glucose sensing determines intermediary metabolism in liver

Journal of Clinical Investigation

Volumn 122, Issue 8, 2012, Pages 2817-2826

  Oosterveer, Maaike H ^a   Mataki, Chikage ^a   Yamamoto, Hiroyasu ^a   Harach, Taoufiq ^a   Moullan, Norman ^a   Van Dijk, Theo H ^b   Ayuso, Eduard ^c,d   Bosch, Fatima ^c,d   Postic, Catherine ^e   Groen, Albert K ^b   Auwerx, Johan ^a   Schoonjans, Kristina ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOKINASE; GLUCOSE; GLYCOGEN SYNTHASE; INSULIN; LIVER RECEPTOR HOMOLOG 1; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; INSULIN BLOOD LEVEL; LIPOGENESIS; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; GLUCOKINASE; GLUCOSE; GLYCOGEN SYNTHASE; GLYCOLYSIS; LIPID METABOLISM; LIVER; LIVER GLYCOGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84864752368     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62368     Document Type: Article

References (56)

1. Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17(6):292-301. (Pubitemid 46829846)
2. McKenna NJ, et al. Minireview: evolution of NURSA, the nuclear receptor signaling atlas. Mol Endocrinol. 2009;23(6):740-746.
3. Mataki C, et al. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol. 2007;27(23):8330-8339. (Pubitemid 350234244)
4. Out C, et al. Liver receptor homolog-1 is critical for adequate up-regulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration. Hepatology. 2011;53(6):2075-2085.
5. Lee YK, et al. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol Endocrinol. 2008;22(6):1345-1356.
6. Venteclef N, Smith JC, Goodwin B, Delerive P. Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Mol Cell Biol. 2006;26(18):6799-6807. (Pubitemid 44387630)
7. Venteclef N, Delerive P. Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response. J Biol Chem. 2007;282(7):4393-4399. (Pubitemid 47100919)
8. Schoonjans K, et al. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep. 2002;3(12):1181-1187. (Pubitemid 36105008)
9. Freeman LA, et al. The orphan nuclear receptor LRH-1 activates the ABCG5/ABCG8 intergenic promoter. J Lipid Res. 2004;45(7):1197-1206. (Pubitemid 38802623)
10. Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B. Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol Endocrinol. 2004;18(10):2378-2387. (Pubitemid 39335974)
11. Venteclef N, Haroniti A, Tousaint JJ, Talianidis I, Delerive P. Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1. J Biol Chem. 2008;283(7):3694-3701.
12. Luo Y, Liang CP, Tall AR. The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J Biol Chem. 2001;276(27):24767-24773.
13. Matsukuma KE, Wang L, Bennett MK, Osborne TF. A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor. J Biol Chem. 2007;282(28):20164-20171. (Pubitemid 47099984)
14. Lee YK, Moore DD. Liver receptor homolog-1, an emerging metabolic modulator. Front Biosci. 2008;13:5950-5958.
15. Ingraham HA, Redinbo MR. Orphan nuclear receptors adopted by crystallography. Curr Opin Struct Biol. 2005;15(6):708-715. (Pubitemid 41668528)
16. Mullaney BC, et al. Regulation of C. elegans fat uptake and storage by acyl-CoA synthase-3 is dependent on NR5A family nuclear hormone receptor nhr-25. Cell Metab. 2010;12(4):398-410.
17. Musille PM, Pathak MC, Lauer JL, Hudson WH, Griffin PR, Ortlund EA. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol. 2012;19(5):532-537.
18. Lee JM, et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature. 2011;474(7352):506-510.
19. Derks TG, et al. Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice. Hepatology. 2008;47(3):1032-1042. (Pubitemid 351449694)
20. Lee YK, Moore DD. Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner. J Biol Chem. 2002;277(4):2463-2467. (Pubitemid 34953268)
21. Postic C, et al. Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites. Genomics. 1995;29(3):740-750.
22. Postic C, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274(1):305-315. (Pubitemid 29035064)
23. Dentin R, et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem. 2004;279(19):20314-20326. (Pubitemid 38623477)
24. Dentin R, et al. Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol. 2012;56(1):199-209.
25. Li MV, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010;395(3):395-400.
26. Fayard E, Auwerx J, Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 2004;14(5):250-260. (Pubitemid 38591329)
27. Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA. Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem. 1997;272(36):22570-22575. (Pubitemid 27386069)
28. Iynedjian PB. Mammalian glucokinase and its gene. Biochem J. 1993;293(pt 1):1-13. (Pubitemid 23223139)
29. Kim TH, et al. Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver. J Biol Chem. 2009;284(22):15071-15083.
30. Oosterveer MH, et al. Lxralpha deficiency hampers the hepatic adaptive response to fasting in mice. J Biol Chem. 2008;283(37):25437-25445.
31. Denechaud PD, et al. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest. 2008;118(3):956-964.
32. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem. 2002;277(11):9520-9528. (Pubitemid 34953041)
33. Park YJ, et al. Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner. J Lipid Res. 2011;52(12):2234-2244.
34. Seoane J, Gomez-Foix AM, O'Doherty RM, Gomez-Ara C, Newgard CB, Guinovart JJ. Glucose 6-phosphate produced by glucokinase, but not hexokinase I, promotes the activation of hepatic glycogen synthase. J Biol Chem. 1996;271(39):23756- 23760. (Pubitemid 26327344)
35. O'Doherty RM, Lehman DL, Seoane J, Gomez-Foix AM, Guinovart JJ, Newgard CB. Differential metabolic effects of adenovirus-mediated glucokinase and hexokinase I overexpression in rat primary hepatocytes. J Biol Chem. 1996;271(34):20524-20530. (Pubitemid 26281826)
36. Bandsma RH, et al. Enhanced glucose cycling and suppressed de novo synthesis of glucose- 6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice. Diabetologia. 2004;47(11):2022-2031. (Pubitemid 40110214)
37. Hron WT, Sobocinski KA, Menahan LA. Enzyme activities of hepatic glucose utilization in the fed and fasting genetically obese mouse at 4-5 months of age. Horm Metab Res. 1984;16(suppl 1):32-36. (Pubitemid 15088862)
38. Yen TT, Stamm NB. Constitutive hepatic glucokinase activity in db/db and ob/ob mice. Biochim Biophys Acta. 1981;657(1):195-202. (Pubitemid 11181777)
39. Dentin R, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55(8):2159-2170. (Pubitemid 44743612)
40. Peter A, et al. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab. 2011;96(7):E1126-E1130.
41. Scott DK, et al. A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression. Mol Cell Biochem. 2003;254(1-2):327-337. (Pubitemid 37483769)
42. Manno CS, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12(3):342-347. (Pubitemid 43355084)
43. Ayuso E, et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther. 2010; 17(4):503-510.
44. Lock M, et al. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther. 2010;21(10):1273-1285.
45. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology. 1985;88(2):403-411. (Pubitemid 15194702)
46. Van Dijk TH, Boer TS, Havinga R, Stellaard F, Kuipers F, Reijngoud DJ. Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. Anal Biochem. 2003; 322(1):1-13. (Pubitemid 37188550)
47. Lee WN, Byerley LO, Bergner EA, Edmond J. Mass isotopomer analysis: theoretical and practical considerations. Biol Mass Spectrom. 1991;20(8):451-458.
48. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917.
49. Oosterveer MH, et al. High fat feeding induces hepatic fatty acid elongation in mice. PLoS One. 2009;4(6):e6066.
50. Hohorst HJ. D-Glucose-6-phosphat und D-fructose-6-phosphat. In: Bergmeyer HU, ed. Methoden der Enzymatischen Analyse. Weinheim, Germany; Verlag Chemie: 1970:1200-1204.
51. Keppler D, Decker K. Glykogen. Bestimmung mit amyloglucosidase. In: Bergmeyer HU, ed. Methoden der Enzymatischen Analyse. Weinheim, Germany; Verlag Chemie: 1970:1089-1094.
52. Mullin JM, McGinn MT, Snock KV, Kofeldt LM. Na+-independent sugar transport by cultured renal (LLC-PK1) epithelial cells. Am J Physiol. 1989; 257(1 pt 2):F11-F17.
53. Gauthier K, et al. Thyroid hormone receptor beta (TRbeta) and liver X receptor (LXR) regulate carbohydrate-response element-binding protein (ChREBP) expression in a tissue-selective manner. J Biol Chem. 2010;285(36):28156-28163.
54. Duggavathi R, et al. Liver receptor homolog 1 is essential for ovulation. Genes Dev. 2008;22(14):1871-1876. (Pubitemid 352008636)
55. Liang Y, Jetton TL, Zimmerman EC, Najafi H, Matschinsky FM, Magnuson MA. Effects of alternate RNA splicing on glucokinase isoform activities in the pancreatic islet, liver, and pituitary. J Biol Chem. 1991;266(11):6999-7007. (Pubitemid 21906323)
56. Coste A, et al. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc Natl Acad Sci U S A. 2007;104(32):13098-13103. (Pubitemid 351737599)